Stock Analysis
- Canada
- /
- Healthtech
- /
- TSXV:CRBK
Carebook Technologies Third Quarter 2023 Earnings: CA$0.004 loss per share (vs CA$0.022 loss in 3Q 2022)
Carebook Technologies (CVE:CRBK) Third Quarter 2023 Results
Key Financial Results
- Revenue: CA$3.48m (up 69% from 3Q 2022).
- Net loss: CA$390.0k (loss narrowed by 77% from 3Q 2022).
- CA$0.004 loss per share (improved from CA$0.022 loss in 3Q 2022).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Carebook Technologies shares are up 15% from a week ago.
Risk Analysis
Don't forget that there may still be risks. For instance, we've identified 6 warning signs for Carebook Technologies (5 shouldn't be ignored) you should be aware of.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About TSXV:CRBK
Carebook Technologies
Engages in the development and commercialization of digital health platforms for assessments, reporting, and targeted solutions in Canada, the United States, Europe, Latin America, Asia, and internationally.